| Original language | English (US) |
|---|---|
| Pages (from-to) | 545-548 |
| Number of pages | 4 |
| Journal | Therapeutic Delivery |
| Volume | 2 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2011 |
Fingerprint
Drug Delivery Systems
Particle Size
Antineoplastic Agents
Nanoparticles
Neoplasms
Therapeutics
Keywords
- biodistribution
- cancer
- drug delivery
- nanoparticles
- triggered release
- tumor targeting
ASJC Scopus subject areas
- Pharmaceutical Science
Cite this
Berti, L. (2011). Challenges of nanoparticle engineering for cancer therapeutics. Therapeutic Delivery, 2(5), 545-548. https://doi.org/10.4155/tde.11.36
Challenges of nanoparticle engineering for cancer therapeutics. / Berti, Lorenzo.
In: Therapeutic Delivery, Vol. 2, No. 5, 05.2011, p. 545-548.Research output: Contribution to journal › Article
Berti, L 2011, 'Challenges of nanoparticle engineering for cancer therapeutics', Therapeutic Delivery, vol. 2, no. 5, pp. 545-548. https://doi.org/10.4155/tde.11.36
Berti L. Challenges of nanoparticle engineering for cancer therapeutics. Therapeutic Delivery. 2011 May;2(5):545-548. https://doi.org/10.4155/tde.11.36
@article{6a9c7abf929044628cd13aaff2d88aa2,
title = "Challenges of nanoparticle engineering for cancer therapeutics",
keywords = "biodistribution, cancer, drug delivery, nanoparticles, triggered release, tumor targeting",
author = "Lorenzo Berti",
year = "2011",
month = "5",
doi = "10.4155/tde.11.36",
language = "English (US)",
volume = "2",
pages = "545--548",
journal = "Therapeutic Delivery",
issn = "2041-5990",
publisher = "Future Science",
number = "5",
}
TY - JOUR
T1 - Challenges of nanoparticle engineering for cancer therapeutics
AU - Berti, Lorenzo
PY - 2011/5
Y1 - 2011/5
KW - biodistribution
KW - cancer
KW - drug delivery
KW - nanoparticles
KW - triggered release
KW - tumor targeting
UR - http://www.scopus.com/inward/record.url?scp=79956154874&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79956154874&partnerID=8YFLogxK
U2 - 10.4155/tde.11.36
DO - 10.4155/tde.11.36
M3 - Article
VL - 2
SP - 545
EP - 548
JO - Therapeutic Delivery
JF - Therapeutic Delivery
SN - 2041-5990
IS - 5
ER -